{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T12:12:42Z","timestamp":1794658362215,"version":"4.9.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,22]],"date-time":"2023-01-22T00:00:00Z","timestamp":1674345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,22]],"date-time":"2023-01-22T00:00:00Z","timestamp":1674345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2018-02124"],"award-info":[{"award-number":["2018-02124"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2022-00799"],"award-info":[{"award-number":["2022-00799"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007817","name":"Alcon Research Institute","doi-asserted-by":"publisher","award":["Young Investigator"],"award-info":[{"award-number":["Young Investigator"]}],"id":[{"id":"10.13039\/100007817","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010810","name":"\u00d6gonfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010810","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Glaucoma is the leading cause of irreversible blindness and is a major health and economic burden. Current treatments do not address the neurodegenerative component of glaucoma. In animal models of glaucoma, the capacity to maintain retinal nicotinamide adenine dinucleotide (NAD) pools declines early during disease pathogenesis. Treatment with nicotinamide, an NAD precursor through the NAD salvage pathway, robustly protects against neurodegeneration in a number of glaucoma models and improves vision in existing glaucoma patients. However, it remains unknown in humans what retinal cell types are able to process nicotinamide to NAD and how these are affected in glaucoma. To address this, we utilized publicly available RNA-sequencing data (bulk, single cell, and single nucleus) and antibody labelling in highly preserved enucleated human eyes to identify expression of NAD synthesizing enzyme machinery. This identifies that the neural retina favors expression of the NAD salvage pathway, and that retinal ganglion cells are particularly enriched for these enzymes. NMNAT2, a key terminal enzyme in the salvage pathway, is predominantly expressed in retinal ganglion cell relevant layers of the retina and declines in glaucoma. These findings suggest that human retinal ganglion cells can directly utilize nicotinamide and could maintain a capacity to do so in glaucoma, showing promise for ongoing clinical trials.<\/jats:p>","DOI":"10.1186\/s40478-023-01513-0","type":"journal-article","created":{"date-parts":[[2023,1,22]],"date-time":"2023-01-22T02:02:33Z","timestamp":1674352953000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["NAD salvage pathway machinery expression in normal and glaucomatous retina and optic nerve"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8301-7358","authenticated-orcid":false,"given":"James R.","family":"Tribble","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Hagstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenza","family":"Jusseaume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Lardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8092-9455","authenticated-orcid":false,"given":"Raymond Ching-Bong","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustav","family":"St\u00e5lhammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6194-8397","authenticated-orcid":false,"given":"Pete A.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,22]]},"reference":[{"key":"1513_CR1","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/science.aac4854","volume":"350","author":"E Verdin","year":"2015","unstructured":"Verdin E (2015) NAD+ in aging, metabolism, and neurodegeneration. Science 350:1208\u20131213","journal-title":"Science"},{"key":"1513_CR2","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"YC Tham","year":"2014","unstructured":"Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY (2014) Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 121:2081\u20132090","journal-title":"Ophthalmology"},{"key":"1513_CR3","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1126\/science.aal0092","volume":"355","author":"PA Williams","year":"2017","unstructured":"Williams PA, Harder JM, Foxworth NE, Cochran KE, Philip VM, Porciatti V et al (2017) Vitamin B-3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice. Science 355:756\u2013760","journal-title":"Science"},{"key":"1513_CR4","doi-asserted-by":"publisher","first-page":"fcz035","DOI":"10.1093\/braincomms\/fcz035","volume":"1","author":"JR Tribble","year":"2019","unstructured":"Tribble JR, Vasalauskaite A, Redmond T, Young RD, Hassan S, Fautsch MP et al (2019) Midget retinal ganglion cell dendritic and mitochondrial degeneration is an early feature of human glaucoma. Brain Commun 1:fcz035","journal-title":"Brain Commun"},{"key":"1513_CR5","doi-asserted-by":"crossref","unstructured":"Harder JM, Guymer C, Wood JPM, Daskalaki E, Chidlow G, Zhang C, et al. Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin. Proc Natl Acad Sci U S A 2020","DOI":"10.1073\/pnas.2014213117"},{"key":"1513_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101988","volume":"43","author":"JR Tribble","year":"2021","unstructured":"Tribble JR, Otmani A, Sun S, Ellis SA, Cimaglia G, Vohra R et al (2021) Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction. Redox Biol 43:101988","journal-title":"Redox Biol"},{"key":"1513_CR7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.freeradbiomed.2022.07.009","volume":"189","author":"NA Vallabh","year":"2022","unstructured":"Vallabh NA, Armstrong J, Czanner G, McDonagh B, Choudhary A, Criddle DN et al (2022) Evidence of impaired mitochondrial cellular bioenergetics in ocular fibroblasts derived from glaucoma patients. Free Radic Biol Med 189:102\u2013110","journal-title":"Free Radic Biol Med"},{"key":"1513_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157404","volume":"11","author":"A Want","year":"2016","unstructured":"Want A, Gillespie SR, Wang Z, Gordon R, Iomini C, Ritch R et al (2016) Autophagy and mitochondrial dysfunction in Tenon fibroblasts from exfoliation glaucoma patients. PLoS ONE 11:e0157404","journal-title":"PLoS ONE"},{"key":"1513_CR9","doi-asserted-by":"crossref","unstructured":"Chou TH, Romano GL, Amato R, Porciatti V (2020) Nicotinamide-rich diet in DBA\/2J mice preserves retinal ganglion cell metabolic function as assessed by PERG adaptation to flicker. Nutrients 12","DOI":"10.3390\/nu12071910"},{"key":"1513_CR10","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1167\/iovs.19-27099","volume":"60","author":"J Kouassi Nzoughet","year":"2019","unstructured":"Kouassi Nzoughet J, Chao de la Barca JM, Guehlouz K, Leruez S, Coulbault L, Allouche S et al (2019) Nicotinamide deficiency in primary open-angle glaucoma. Invest Ophthalmol Vis Sci 60:2509\u20132514","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1513_CR11","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1111\/ceo.13818","volume":"48","author":"F Hui","year":"2020","unstructured":"Hui F, Tang J, Williams PA, McGuinness MB, Hadoux X, Casson RJ et al (2020) Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: a crossover randomized clinical trial. Clin Exp Ophthalmol 48:903\u2013914","journal-title":"Clin Exp Ophthalmol"},{"key":"1513_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1001\/jamaophthalmol.2021.4576","volume":"140","author":"CG De Moraes","year":"2022","unstructured":"De Moraes CG, John SWM, Williams PA, Blumberg DM, Cioffi GA, Liebmann JM (2022) Nicotinamide and pyruvate for neuroenhancement in open-angle glaucoma: a phase 2 randomized clinical trial. JAMA Ophthalmol 140:11\u201318","journal-title":"JAMA Ophthalmol"},{"key":"1513_CR13","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s40478-022-01427-3","volume":"10","author":"C Rutigliani","year":"2022","unstructured":"Rutigliani C, Tribble JR, Hagstr\u00f6m A, Lardner E, J\u00f3hannesson G, St\u00e5lhammar G et al (2022) Widespread retina and optic nerve neuroinflammation in enucleated eyes from glaucoma patients. Acta Neuropathol Commun 10:118","journal-title":"Acta Neuropathol Commun"},{"key":"1513_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2147\/EB.S226319","volume":"12","author":"G Scuderi","year":"2020","unstructured":"Scuderi G, Fragiotta S, Scuderi L, Iodice CM, Perdicchi A (2020) Ganglion cell complex analysis in glaucoma patients: What can it tell us? Eye Brain 12:33\u201344","journal-title":"Eye Brain"},{"key":"1513_CR15","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.celrep.2019.12.082","volume":"30","author":"LD Orozco","year":"2020","unstructured":"Orozco LD, Chen HH, Cox C, Katschke KJ, Arceo R, Espiritu C et al (2020) Integration of eQTL and a single-cell atlas in the human eye identifies causal genes for age-related macular degeneration. Cell Rep 30:1246\u201359.e6","journal-title":"Cell Rep"},{"key":"1513_CR16","doi-asserted-by":"publisher","first-page":"5675","DOI":"10.1038\/s41467-021-25968-8","volume":"12","author":"P Gautam","year":"2021","unstructured":"Gautam P, Hamashima K, Chen Y, Zeng Y, Makovoz B, Parikh BH et al (2021) Multi-species single-cell transcriptomic analysis of ocular compartment regulons. Nat Commun 12:5675","journal-title":"Nat Commun"},{"key":"1513_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076938","volume":"8","author":"R Felici","year":"2013","unstructured":"Felici R, Lapucci A, Ramazzotti M, Chiarugi A (2013) Insight into molecular and functional properties of NMNAT3 reveals new hints of NAD homeostasis within human mitochondria. PLoS ONE 8:e76938","journal-title":"PLoS ONE"},{"key":"1513_CR18","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.cmet.2019.09.001","volume":"30","author":"S Lautrup","year":"2019","unstructured":"Lautrup S, Sinclair DA, Mattson MP, Fang EF (2019) NAD. Cell Metab 30:630\u2013655","journal-title":"Cell Metab"},{"key":"1513_CR19","doi-asserted-by":"crossref","unstructured":"Williams PA, Harder JM, Foxworth NE, Cardozo BH, Cochran KE, John SWM (2017) Nicotinamide and WLDS act together to prevent neurodegeneration in glaucoma. Front Neurosci 11","DOI":"10.3389\/fnins.2017.00232"},{"key":"1513_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002472","volume":"14","author":"YO Ali","year":"2016","unstructured":"Ali YO, Allen HM, Yu L, Li-Kroeger D, Bakhshizadehmahmoudi D, Hatcher A et al (2016) NMNAT2:HSP90 complex mediates proteostasis in proteinopathies. PLoS Biol 14:e1002472","journal-title":"PLoS Biol"},{"key":"1513_CR21","doi-asserted-by":"publisher","DOI":"10.1080\/19420889.2017.1356956","volume":"11","author":"PA Williams","year":"2018","unstructured":"Williams PA, Harder JM, Cardozo BH, Foxworth NE, John SWM (2018) Nicotinamide treatment robustly protects from inherited mouse glaucoma. Commun Integr Biol 11:e1356956","journal-title":"Commun Integr Biol"},{"key":"1513_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000300","volume":"8","author":"J Gilley","year":"2010","unstructured":"Gilley J, Coleman MP (2010) Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons. PLoS Biol 8:e1000300","journal-title":"PLoS Biol"},{"key":"1513_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/nm.1913","volume":"15","author":"J Skokowa","year":"2009","unstructured":"Skokowa J, Lan D, Thakur BK, Wang F, Gupta K, Cario G et al (2009) NAMPT is essential for the G-CSF-induced myeloid differentiation via a NAD(+)-sirtuin-1-dependent pathway. Nat Med 15:151\u2013158","journal-title":"Nat Med"},{"key":"1513_CR24","doi-asserted-by":"publisher","first-page":"8167273","DOI":"10.1155\/2016\/8167273","volume":"2016","author":"VT Vachharajani","year":"2016","unstructured":"Vachharajani VT, Liu T, Wang X, Hoth JJ, Yoza BK, McCall CE (2016) Sirtuins link inflammation and metabolism. J Immunol Res 2016:8167273","journal-title":"J Immunol Res"},{"key":"1513_CR25","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/jnc.14811","volume":"150","author":"YB Lu","year":"2019","unstructured":"Lu YB, Chen CX, Huang J, Tian YX, Xie X, Yang P et al (2019) Nicotinamide phosphoribosyltransferase secreted from microglia via exosome during ischemic injury. J Neurochem 150:723\u2013737","journal-title":"J Neurochem"},{"key":"1513_CR26","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.neuroscience.2017.05.022","volume":"356","author":"CX Chen","year":"2017","unstructured":"Chen CX, Huang J, Tu GQ, Lu JT, Xie X, Zhao B et al (2017) NAMPT inhibitor protects ischemic neuronal injury in rat brain via anti-neuroinflammation. Neuroscience 356:193\u2013206","journal-title":"Neuroscience"},{"key":"1513_CR27","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/cdd.2014.164","volume":"22","author":"M Di Stefano","year":"2015","unstructured":"Di Stefano M, Nascimento-Ferreira I, Orsomando G, Mori V, Gilley J, Brown R et al (2015) A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration. Cell Death Differ 22:731\u2013742","journal-title":"Cell Death Differ"},{"key":"1513_CR28","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/ng.2356","volume":"44","author":"RK Koenekoop","year":"2012","unstructured":"Koenekoop RK, Wang H, Majewski J, Wang X, Lopez I, Ren H et al (2012) Mutations in NMNAT1 cause Leber congenital amaurosis and identify a new disease pathway for retinal degeneration. Nat Genet 44:1035\u20131039","journal-title":"Nat Genet"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-023-01513-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-023-01513-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-023-01513-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,22]],"date-time":"2023-01-22T02:02:44Z","timestamp":1674352964000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-023-01513-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,22]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1513"],"URL":"https:\/\/doi.org\/10.1186\/s40478-023-01513-0","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,22]]},"assertion":[{"value":"5 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Access to histopathology archive samples was fully covered through biobank #366 (St Erik Eye Hospital). The study adhered to the tenets of the Declaration of Helsinki and the ethics protocols were approved by the Swedish Ethical Review Authority (2020-01525 and 2021-01036).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PAW is an inventor on an awarded US patent held by The Jackson Laboratory for nicotinamide treatment in glaucoma (\u201cTreatment and prevention of ocular neurodegenerative disorder\u201d, US11389439B2). All other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}